Gender-Related Safety and Outcome in Advanced NSCLC Patients Treated with Immune Checkpoint-Inhibitors. A Real-World Experience

被引：0
|
作者：
Pizzutilo, P. [1 ]
Catino, A. [1 ]
Montrone, M. [1 ]
Longo, V. [1 ]
Ricci, D. [1 ]
Pesola, F. [1 ]
Marech, I. [1 ]
Mastrandrea, A. [1 ]
Petrillo, P. [1 ]
Zacheo, A. [1 ]
Varesano, N. [1 ]
Lamorgese, V. [1 ]
Bafunno, D. [1 ]
Galetta, D. [1 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II, Thorac Oncol, Thorac Oncol Unit, Bari, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Immune checkpoint inhibitors; Gender-related outcome; advanced lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P75.14
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [41] Real-World Treatment with Checkpoint Inhibitors: The Swedish Experience
    Gagatek, S.
    Backman, M.
    Mattsson, J.
    Lamberg, K.
    Brostrom, E.
    Botling, J.
    Micke, P.
    Isaksson, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S978 - S978
  • [42] Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study
    Kuusisalo, Saara
    Koivunen, Jussi P.
    Iivanainen, Sanna
    CANCERS, 2022, 14 (09)
  • [43] Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data
    Tarhini, Ahmad A.
    Tan, Aik Choon
    Xie, Mengyu
    El Naqa, Issam
    Saghand, Payman Ghasemi
    Dai, Donghai
    Chen, James Lin
    Ratan, Aakrosh
    McCarter, Martin
    Carpten, John D.
    Colman, Howard
    Ikeguchi, Alexandra
    Tripathi, Abhishek
    Puzanov, Igor
    Arnold, Susanne M.
    Churchman, Michelle L.
    Hwu, Patrick
    Conejo-Garcia, Jose
    Dalton, William S.
    Weiner, George J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence
    Hein, Erica C. Koch
    Vilbert, Maysa
    Hirsch, Ian
    Ribeiro, Mauricio Fernando
    Mantle, Luke
    Fournier, Cynthia
    Butler, Marcus O.
    Spreafico, Anna
    Saibil, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence.
    Crawley, Danielle
    Beckmann, Kerri
    Ravindra, Saranya
    Josephs, Debra Hannah
    Spicer, James F.
    Montes, Ana
    Karapanagiotou, Eleni
    Ghosh, Sharmistha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world
    Hao, Wen
    Liu, Wenjing
    Chang, Ruimin
    Yang, Mi
    Xin, Kai
    Liu, Jingxin
    Wang, Yibing
    Ren, Meijin
    Xie, Jiaqi
    Yang, Yang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (04)
  • [47] Safety and efficacy of first-line immune checkpoint inhibitors in elderly colorectal cancer patients: An Italian real-world multicenter experience
    Boccaccino, A.
    Frapoli, M.
    Rossini, D.
    Salvatore, L.
    Passardi, A.
    Papiani, G.
    Valsecchi, A. A.
    Puccini, A.
    Massaro, G.
    Santucci, S.
    Guidolin, A.
    Spring, A.
    Romagnani, E.
    Tamberi, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S448 - S448
  • [48] Proton Pump Inhibitors, Prior Therapy and Survival in Patients Treated With Immune Checkpoint Inhibitors for Advanced NSCLC
    Husain, M.
    Xu, M.
    Patel, S.
    Johns, A.
    Grogan, M.
    Li, M.
    Lopez, G.
    Miah, A.
    Hoyd, R.
    Liu, Y.
    Muniak, M.
    Haddad, T.
    Tinoco, G.
    Kendra, K.
    Otterson, G.
    Presley, C.
    Spakowicz, D.
    Owen, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1076 - S1076
  • [49] The impact of prior immune checkpoint inhibitors or osimertinib treatment on NSCLC patients receiving atezolizumab treatment: A real-world observation
    Wu, S-G.
    Chiang, C-L.
    Wang, C-C.
    Hung, J-Y.
    Hsia, T-C.
    Kuo, C-H.
    Shih, J-Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S777 - S777
  • [50] Characterization of risk factors and efficacy of medical management of immune-related hepatotoxicity in real-world patients with metastatic melanoma treated with immune checkpoint inhibitors
    Romanski, Nicole A.
    Holmstroem, Ikke B.
    Ellebaek, Eva
    Svane, Inge Marie
    EUROPEAN JOURNAL OF CANCER, 2020, 130 : 211 - 218
12345